1
|
Driessen HP, de Jong WW, Tesser GI and
Bloemendal H: The mechanism of N-terminal acetylation of proteins.
CRC Crit Rev Biochem. 18:281–325. 1985. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jeong JW, Bae MK, Ahn MY, et al:
Regulation and destabilization of HIF-1alpha by ARD1-mediated
acetylation. Cell. 111:709–720. 2002. View Article : Google Scholar : PubMed/NCBI
|
3
|
Lim JH, Park JW and Chun YS: Human arrest
defective 1 acetylates and activates beta-catenin, promoting lung
cancer cell proliferation. Cancer Res. 66:10677–10682. 2006.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Ohkawa N, Sugisaki S, Tokunaga E, et al:
N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic
development. Genes Cells. 13:1171–1183. 2008.PubMed/NCBI
|
5
|
Shin DH, Chun YS, Lee KH, Shin HW and Park
JW: Arrest defective-1 controls tumor cell behavior by acetylating
myosin light chain kinase. PLoS One. 4:e74512009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wang Z, Wang Z, Guo J, et al: Inactivation
of androgen-induced regulator ARD1 inhibits androgen receptor
acetylation and prostate tumorigenesis. Proc Natl Acad Sci USA.
109:3053–3058. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kuo HP, Lee DF, Chen CT, et al: ARD1
stabilization of TSC2 suppresses tumorigenesis through the mTOR
signaling pathway. Sci Signal. 3:ra92010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Xu H, Jiang B, Meng L, et al:
N-α-acetyltransferase 10 protein inhibits apoptosis through
RelA/p65-regulated MCL1 expression. Carcinogenesis. 33:1193–1202.
2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Yi CH, Sogah DK, Boyce M, Degterev A,
Christofferson DE and Yuan J: A genome-wide RNAi screen reveals
multiple regulators of caspase activation. J Cell Biol.
179:619–626. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Arnesen T, Gromyko D, Pendino F, Ryningen
A, Varhaug JE and Lillehaug JR: Induction of apoptosis in human
cells by RNAi-mediated knockdown of hARD1 and NATH, components of
the protein N-alpha-acetyltransferase complex. Oncogene.
25:4350–4360. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Asaumi M, Iijima K, Sumioka A, et al:
Interaction of N-terminal acetyltransferase with the cytoplasmic
domain of beta-amyloid precursor protein and its effect on A beta
secretion. J Biochem. 137:147–155. 2005. View Article : Google Scholar : PubMed/NCBI
|
12
|
Arnesen T, Anderson D, Baldersheim C,
Lanotte M, Varhaug JE and Lillehaug JR: Identification and
characterization of the human ARD1-NATH protein acetyltransferase
complex. Biochem J. 386:433–443. 2005. View Article : Google Scholar :
|
13
|
Kuo HP and Hung MC: Arrest-defective-1
protein (ARD1): tumor suppressor or oncoprotein? Am J Transl Res.
2:56–64. 2010.PubMed/NCBI
|
14
|
Kalvik TV and Arnesen T: Protein
N-terminal acetyltransferases in cancer. Oncogene. 32:269–276.
2013. View Article : Google Scholar
|
15
|
Arnesen T, Thompson PR, Varhaug JE and
Lillehaug JR: The protein acetyltransferase ARD1: a novel cancer
drug target? Curr Cancer Drug Targets. 8:545–553. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Shim JH, Chung YH, Kim JA, et al: Clinical
implications of arrest-defective protein 1 expression in
hepatocellular carcinoma: a novel predictor of microvascular
invasion. Dig Dis. 30:603–608. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Wang ZH, Gong JL, Yu M, et al:
Up-regulation of human arrest-defective 1 protein is correlated
with metastatic phenotype and poor prognosis in breast cancer.
Asian Pac J Cancer Prev. 12:1973–1977. 2011.
|
18
|
Yu M, Gong J, Ma M, et al:
Immunohistochemical analysis of human arrest-defective-1 expressed
in cancers in vivo. Oncol Rep. 21:909–915. 2009.PubMed/NCBI
|
19
|
Ren T, Jiang B, Jin G, et al: Generation
of novel monoclonal antibodies and their application for detecting
ARD1 expression in colorectal cancer. Cancer Lett. 264:83–92. 2008.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Arnesen T, Gromyko D, Horvli O, Fluge O,
Lillehaug J and Varhaug JE: Expression of N-acetyl transferase
human and human arrest defective 1 proteins in thyroid neoplasms.
Thyroid. 15:1131–1136. 2005. View Article : Google Scholar : PubMed/NCBI
|
21
|
Seo JH, Cha JH, Park JH, et al: Arrest
defective 1 autoacetylation is a critical step in its ability to
stimulate cancer cell proliferation. Cancer Res. 70:4422–4432.
2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Chun KH, Cho SJ, Choi JS, Kim SH, Kim KW
and Lee SK: Differential regulation of splicing, localization and
stability of mammalian ARD1235 and ARD1225 isoforms. Biochem
Biophys Res Commun. 353:18–25. 2007. View Article : Google Scholar
|
23
|
Kim SH, Park JA, Kim JH, et al:
Characterization of ARD1 variants in mammalian cells. Biochem
Biophys Res Commun. 340:422–427. 2006. View Article : Google Scholar
|
24
|
Arnesen T, Kong X, Evjenth R, et al:
Interaction between HIF-1 alpha (ODD) and hARD1 does not induce
acetylation and destabilization of HIF-1 alpha. FEBS Lett.
579:6428–6432. 2005. View Article : Google Scholar : PubMed/NCBI
|
25
|
Bilton R, Mazure N, Trottier E, et al:
Arrest-defective-1 protein, an acetyltransferase, does not alter
stability of hypoxia-inducible factor (HIF)-1alpha and is not
induced by hypoxia or HIF. J Biol Chem. 280:31132–31140. 2005.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Fisher TS, Etages SD, Hayes L, Crimin K
and Li B: Analysis of ARD1 function in hypoxia response using
retroviral RNA interference. J Biol Chem. 280:17749–17757. 2005.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Lee MN, Lee SN, Kim SH, et al: Roles of
arrest-defective protein 1(225) and hypoxia-inducible factor 1alpha
in tumor growth and metastasis. J Natl Cancer Inst. 102:426–442.
2010. View Article : Google Scholar : PubMed/NCBI
|
28
|
Brett D, Pospisil H, Valcarcel J, Reich J
and Bork P: Alternative splicing and genome complexity. Nat Genet.
30:29–30. 2002. View
Article : Google Scholar
|
29
|
Nilsen TW and Graveley BR: Expansion of
the eukaryotic proteome by alternative splicing. Nature.
463:457–463. 2010. View Article : Google Scholar : PubMed/NCBI
|